Mode
Text Size
Log in / Sign up
N/A N=42 Randomized Treatment

A Randomized Cross Over Trial of Two Treatments for Sleep Apnea in Veterans With Post-Traumatic Stress Disorder

Obstructive Sleep Apnea

Enrolled (actual)
42
Serious AEs
0.0%
Results posted
Nov 2017
Primary outcome: Primary: Residual Apnea Hypopnea Index — 3.9; 26.3 events per hour — p=<0.001

Study Design & Population

Study type
Interventional
Phase
N/A
Interventions
CPAP (Device); MAD (Device)
Age
Adult, Older Adult · 18+ yrs
Sex
All
Sponsor
VA Office of Research and Development
Primary completion
Oct 2016

Outcome Measures

OutcomeResultp-value
PRIMARY
Residual Apnea Hypopnea Index
3.9; 26.3 <0.001 sig
SECONDARY
Health Outcomes
9.4; 9.5; 49.9; 50.03; 17.3; 17.3 0.97
SECONDARY
General Health SF-36
49.33; 50.58 0.54
SECONDARY
Adherence to Therapy
3.4; 5.66 <0.001 sig

Summary

Sleep disturbances are cardinal features of Veterans with post traumatic stress disorder (PTSD). In particular, obstructive sleep apnea is reported to occur more frequently in patients with PTSD compared to those without PTSD and contribute to worsening cognitive and behavioral functions. Continuous positive airway pressure (CPAP) is considered the treatment of choice for OSA but adherence to CPAP in Veterans with PTSD is poor compared to the general population. The proposed study aims at comparing the efficacy, tolerability, and adherence of oral appliances-an alternative therapy to OSA- to CPAP. The study is instrumental in identifying the optimal OSA therapy for Veterans with PTSD and the OSA phenotype that would predict oral appliance response

Eligibility Criteria

Inclusion Criteria

  • Consecutive patients aged 18-70 years of age
  • Documented obstructive sleep apnea by polysomnography (AHI 5 or more/hr)
  • Established diagnosis of PTSD related to any past lifetime traumatic event and have a diagnosis of current, chronic PTSD

Exclusion Criteria

  • Central sleep apnea defined as central apnea/hypopnea >50% of the total respiratory events
  • Prior treatment for sleep apnea
  • Veterans with fewer than 4 teeth remaining in either arch
  • Coexisting narcolepsy
  • Tempo-mandibular joint disease
  • Epilepsy
  • Prominent suicidal or homicidal ideation
  • Diagnosis of dementia
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT01569022). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.

Back to search